Beta-adrenergic signaling, a novel target for cancer therapy?
نویسندگان
چکیده
منابع مشابه
Beta-adrenergic signaling, a novel target for cancer therapy?
In the current issue of Oncotarget, a 10-year follow-up study by Powe et al. reports that women receiving beta-blocker therapy for hypertension showed a significant reduction in breast cancer metastasis, recurrence and mortality. These findings provide first clinical evidence in support of earlier in vitro findings by the same research group reporting significant norepinephrine-induced stimulat...
متن کاملThe Canonical Wnt Signaling (Wnt/β-Catenin Pathway): A Potential Target for Cancer Prevention and Therapy
Precise regulation of signal transduction pathways is crucial for normal animal development and for maintaining cellular and tissue homeostasis in adults. The Wnt/Frizzled-mediated signaling includes canonical and non-canonical signal transduction pathways. Upregulation or downregulation of the canonical Wnt-signaling (or the Wnt/β-Catenin signal transduction) leads to a variety of human diseas...
متن کاملMolecular pathways: beta-adrenergic signaling in cancer.
Beta-adrenergic signaling has been found to regulate multiple cellular processes that contribute to the initiation and progression of cancer, including inflammation, angiogenesis, apoptosis/anoikis, cell motility and trafficking, activation of tumor-associated viruses, DNA damage repair, cellular immune response, and epithelial-mesenchymal transition. In several experimental cancer models, acti...
متن کاملChemoimmunotherapy as a Novel Cancer Therapy
Over the past decade, it was widely accepted that some chemotherapeutic drugs can be combined with immunotherapeutic drugs in treatment of cancer. Chemotherapeutic drugs can induce apoptosis in the tumor cell and at the same time stimulate the immune response. Several reports support the use immunomodulators in treatment of cancers through regulating the immune response and boosting the micro...
متن کاملβ2-Microglobulin-mediated Signaling as a Target for Cancer Therapy
β2-microglobulin (β2-m) has become the focus of intense scrutiny since the discovery of its undesirable roles promoting osteomimicry and cancer progression. β2-m is a well-known housekeeping protein that forms complexes with the heavy chain of major histocompatibility complex class I molecules, which are heterodimeric cell surface proteins that present antigenic peptides to cytotoxic T cells. O...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Oncotarget
سال: 2010
ISSN: 1949-2553
DOI: 10.18632/oncotarget.182